Literature DB >> 23893443

Dystonia rating scales: critique and recommendations.

Alberto Albanese1, Francesca Del Sorbo, Cynthia Comella, H A Jinnah, Jonathan W Mink, Bart Post, Marie Vidailhet, Jens Volkmann, Thomas T Warner, Albert F G Leentjens, Pablo Martinez-Martin, Glenn T Stebbins, Christopher G Goetz, Anette Schrag.   

Abstract

Many rating scales have been applied to the evaluation of dystonia, but only few have been assessed for clinimetric properties. The Movement Disorders Society commissioned this task force to critique existing dystonia rating scales and place them in the clinical and clinimetric context. A systematic literature review was conducted to identify rating scales that have either been validated or used in dystonia. Thirty-six potential scales were identified. Eight were excluded because they did not meet review criteria, leaving 28 scales that were critiqued and rated by the task force. Seven scales were found to meet criteria to be "recommended": the Blepharospasm Disability Index is recommended for rating blepharospasm; the Cervical Dystonia Impact Scale and the Toronto Western Spasmodic Torticollis Rating Scale for rating cervical dystonia; the Craniocervical Dystonia Questionnaire for blepharospasm and cervical dystonia; the Voice Handicap Index (VHI) and the Vocal Performance Questionnaire (VPQ) for laryngeal dystonia; and the Fahn-Marsden Dystonia Rating Scale for rating generalized dystonia. Two "recommended" scales (VHI and VPQ) are generic scales validated on few patients with laryngeal dystonia, whereas the others are disease-specific scales. Twelve scales met criteria for "suggested" and 7 scales met criteria for "listed." All the scales are individually reviewed in the online information. The task force recommends 5 specific dystonia scales and suggests to further validate 2 recommended generic voice-disorder scales in dystonia. Existing scales for oromandibular, arm, and task-specific dystonia should be refined and fully assessed. Scales should be developed for body regions for which no scales are available, such as lower limbs and trunk.
© 2013 Movement Disorder Society.

Entities:  

Keywords:  blepharospasm; botulinum neurotoxins; dystonias; rating scales; torticollis

Mesh:

Year:  2013        PMID: 23893443      PMCID: PMC4207366          DOI: 10.1002/mds.25579

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  113 in total

1.  Mexiletine in the treatment of torticollis and generalized dystonia.

Authors:  C Lucetti; A Nuti; G Gambaccini; S Bernardini; S Brotini; M L Manca; U Bonuccelli
Journal:  Clin Neuropharmacol       Date:  2000 Jul-Aug       Impact factor: 1.592

2.  Chronic stimulation of the globus pallidus internus for control of primary generalized dystonia.

Authors:  Y Katayama; C Fukaya; K Kobayashi; H Oshima; T Yamamoto
Journal:  Acta Neurochir Suppl       Date:  2003

3.  Quality-of-life assessment in patients with unilateral vocal cord paralysis.

Authors:  B C Spector; J L Netterville; C Billante; J Clary; L Reinisch; T L Smith
Journal:  Otolaryngol Head Neck Surg       Date:  2001-09       Impact factor: 3.497

4.  Voice handicap index change following treatment of voice disorders.

Authors:  C A Rosen; T Murry; A Zinn; T Zullo; M Sonbolian
Journal:  J Voice       Date:  2000-12       Impact factor: 2.009

5.  Outcomes assessment following treatment of spasmodic dysphonia with botulinum toxin.

Authors:  M S Courey; C G Garrett; C R Billante; R E Stone; M D Portell; T L Smith; J L Netterville
Journal:  Ann Otol Rhinol Laryngol       Date:  2000-09       Impact factor: 1.547

6.  Prospective study of selective peripheral denervation for botulinum-toxin resistant patients with cervical dystonia.

Authors:  A Münchau; J D Palmer; D Dressler; J D O'Sullivan; K L Tsang; M Jahanshahi; N P Quinn; A J Lees; K P Bhatia
Journal:  Brain       Date:  2001-04       Impact factor: 13.501

7.  Use of acupuncture for the treatment of adductor spasmodic dysphonia: a preliminary investigation.

Authors:  Linda Lee; Samantha Daughton; Steven Scheer; Joseph C Stemple; Barbara Weinrich; Tracy Miller-Seiler; Scott Goeller; Linda Levin
Journal:  J Voice       Date:  2003-09       Impact factor: 2.009

8.  Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrument.

Authors:  J Müller; J Wissel; G Kemmler; B Voller; T Bodner; A Schneider; G K Wenning; W Poewe
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-05       Impact factor: 10.154

Review 9.  The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations.

Authors: 
Journal:  Mov Disord       Date:  2003-07       Impact factor: 10.338

10.  Primary dystonia is more responsive than secondary dystonia to pallidal interventions: outcome after pallidotomy or pallidal deep brain stimulation.

Authors:  Hazem A Eltahawy; Jean Saint-Cyr; Nir Giladi; Anthony E Lang; Andres M Lozano
Journal:  Neurosurgery       Date:  2004-03       Impact factor: 4.654

View more
  51 in total

1.  Deep brain stimulation in pediatric dystonia: a systematic review.

Authors:  Andrew T Hale; Meredith A Monsour; John D Rolston; Robert P Naftel; Dario J Englot
Journal:  Neurosurg Rev       Date:  2018-11-05       Impact factor: 3.042

Review 2.  Designing clinical trials for dystonia.

Authors:  Wendy R Galpern; Christopher S Coffey; Alberto Albanese; Ken Cheung; Cynthia L Comella; Dixie J Ecklund; Stanley Fahn; Joseph Jankovic; Karl Kieburtz; Anthony E Lang; Michael P McDermott; Jeremy M Shefner; Jan K Teller; John L P Thompson; Sharon D Yeatts; H A Jinnah
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

3.  Effect of botulinum toxin treatment on quality of life in patients with isolated lingual dystonia and oromandibular dystonia affecting the tongue.

Authors:  Laura Nastasi; Giovanni Mostile; Alessandra Nicoletti; Mario Zappia; Ester Reggio; Santiago Catania
Journal:  J Neurol       Date:  2016-06-08       Impact factor: 4.849

4.  Globus pallidus deep brain stimulation for adult-onset axial dystonia.

Authors:  Aasef G Shaikh; Klaus Mewes; H A Jinnah; Mahlon R DeLong; Robert E Gross; Shirley Triche; Alan Freeman; Stewart A Factor
Journal:  Parkinsonism Relat Disord       Date:  2014-09-16       Impact factor: 4.891

5.  Development and validation of a clinical scale for rating the severity of blepharospasm.

Authors:  Giovanni Defazio; Mark Hallett; Hyder A Jinnah; Glenn T Stebbins; Angelo F Gigante; Gina Ferrazzano; Antonella Conte; Giovanni Fabbrini; Alfredo Berardelli
Journal:  Mov Disord       Date:  2015-04       Impact factor: 10.338

6.  Normalization of sensorimotor integration by repetitive transcranial magnetic stimulation in cervical dystonia.

Authors:  S Zittel; R C Helmich; C Demiralay; A Münchau; T Bäumer
Journal:  J Neurol       Date:  2015-05-28       Impact factor: 4.849

Review 7.  Blepharospasm 40 years later.

Authors:  Giovanni Defazio; Mark Hallett; Hyder A Jinnah; Antonella Conte; Alfredo Berardelli
Journal:  Mov Disord       Date:  2017-02-10       Impact factor: 10.338

8.  Blepharospasm in children and adolescents.

Authors:  Krista Kinard; Neil R Miller; Kathleen B Digre; Bradley J Katz; Alison V Crum; Judith E A Warner
Journal:  Childs Nerv Syst       Date:  2015-10-28       Impact factor: 1.475

9.  Assessment of voice and speech symptoms in early Parkinson's disease by the Robertson dysarthria profile.

Authors:  Giovanni Defazio; Marta Guerrieri; Daniele Liuzzi; Angelo Fabio Gigante; Vincenzo di Nicola
Journal:  Neurol Sci       Date:  2015-11-28       Impact factor: 3.307

10.  Clinimetric testing of the comprehensive cervical dystonia rating scale.

Authors:  Cynthia L Comella; Joel S Perlmutter; Hyder A Jinnah; Tracy A Waliczek; Ami R Rosen; Wendy R Galpern; Charles A Adler; Richard L Barbano; Stewart A Factor; Christopher G Goetz; Joseph Jankovic; Stephen G Reich; Ramon L Rodriguez; William L Severt; Mateusz Zurowski; Susan H Fox; Glenn T Stebbins
Journal:  Mov Disord       Date:  2016-03-12       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.